Rituximab targets podocytes in recurrent focal segmental glomerulosclerosis

Focal segmental glomerulosclerosis (FSGS) is a prevalent glomerular disease characterized by proteinuria, progression to end stage renal disease and recurrence of proteinuria after kidney transplantation in approximately one third of patients. It has been suggested that rituximab might treat recurre...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Fornoni, Alessia, Sageshima, Junichiro, Wei, Changli, Merscher-Gomez, Sandra, Robier, Aguillon-Prada, Jauregui, Alexandra N., Li, Jing, Mattiazzi, Adela, Ciancio, Gaetano, Chen, Linda, Zilleruelo, Gaston, Abitbol, Carolyn, Chandar, Jayanthi, Seeherunvong, Wacheree, Ricordi, Camillo, Ikehata, Masami, Rastaldi, Maria Pia, Reiser, Jochen, Burke, George W.
Format: Artigo
Langue:Inglês
Publié: 2011
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3719858/
https://ncbi.nlm.nih.gov/pubmed/21632984
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1126/scitranslmed.3002231
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires